Filter announcements
Loading...
Incorporated in 1989, Vaishali Pharma Ltddoes marketing of pharmaceutical products including active pharmaceutical ingredients
The Board of Directors of Vaishali Pharma Limited has approved a Share Subscription Agreement to acquire a 51.02% stake in Kesar Pharma Limited by subscribing to 35,89,201 equity shares at a total investment of ₹20.41 Cr. This will be executed in multiple tranches, with ₹8.17 Cr paid in cash and...
For the third quarter ended December 31, 2024, Vaishali Pharma Limited reported consolidated total revenues of ₹2898.20 crore, reflecting a strong revenue growth of 34.69% compared to ₹2149.48 crore in the same period last year. This growth is likely driven by increased demand for pharmaceutical products and effective market expansion...
Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024.